Literature DB >> 26144666

Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach.

Peter C Soema1, Geert-Jan Willems2, Wim Jiskoot3, Jean-Pierre Amorij2, Gideon F Kersten4.   

Abstract

In this study, the effect of liposomal lipid composition on the physicochemical characteristics and adjuvanticity of liposomes was investigated. Using a design of experiments (DoE) approach, peptide-containing liposomes containing various lipids (EPC, DOPE, DOTAP and DC-Chol) and peptide concentrations were formulated. Liposome size and zeta potential were determined for each formulation. Moreover, the adjuvanticity of the liposomes was assessed in an in vitro dendritic cell (DC) model, by quantifying the expression of DC maturation markers CD40, CD80, CD83 and CD86. The acquired data of these liposome characteristics were successfully fitted with regression models, and response contour plots were generated for each response factor. These models were applied to predict a lipid composition that resulted in a liposome with a target zeta potential. Subsequently, the expression of the DC maturation factors for this lipid composition was predicted and tested in vitro; the acquired maturation responses corresponded well with the predicted ones. These results show that a DoE approach can be used to screen various lipids and lipid compositions, and to predict their impact on liposome size, charge and adjuvanticity. Using such an approach may accelerate the formulation development of liposomal vaccine adjuvants.
Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cationic lipids; Dendritic cells; Design of experiments; Liposomes; Maturation markers; Prediction models

Mesh:

Substances:

Year:  2015        PMID: 26144666     DOI: 10.1016/j.ejpb.2015.06.026

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  18 in total

1.  Co-delivery of human cancer-testis antigens with adjuvant in protein nanoparticles induces higher cell-mediated immune responses.

Authors:  Medea Neek; Jo Anne Tucker; Tae Il Kim; Nicholas M Molino; Edward L Nelson; Szu-Wen Wang
Journal:  Biomaterials       Date:  2017-11-20       Impact factor: 12.479

2.  Formulation and evaluation of itraconazole liposomes for Hedgehog pathway inhibition.

Authors:  Jennifer R Pace; Rajan Jog; Diane J Burgess; M Kyle Hadden
Journal:  J Liposome Res       Date:  2019-10-02       Impact factor: 3.648

3.  Implanted synthetic cells trigger tissue angiogenesis through de novo production of recombinant growth factors.

Authors:  Gal Chen; Rotem Levin; Shira Landau; Maya Kaduri; Omer Adir; Iris Ianovici; Nitzan Krinsky; Ofri Doppelt-Flikshtain; Jeny Shklover; Janna Shainsky-Roitman; Shulamit Levenberg; Avi Schroeder
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-12       Impact factor: 12.779

Review 4.  Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance.

Authors:  Noémi Anna Nagy; Aram M de Haas; Teunis B H Geijtenbeek; Ronald van Ree; Sander W Tas; Yvette van Kooyk; Esther C de Jong
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

Review 5.  Recent Advances in Subunit Vaccine Carriers.

Authors:  Abhishek Vartak; Steven J Sucheck
Journal:  Vaccines (Basel)       Date:  2016-04-19

Review 6.  Translational nanoparticle engineering for cancer vaccines.

Authors:  Adam J Grippin; Elias J Sayour; Duane A Mitchell
Journal:  Oncoimmunology       Date:  2017-02-22       Impact factor: 8.110

7.  The role of nanoliposome bilayer composition containing soluble leishmania antigen on maturation and activation of dendritic cells.

Authors:  Sara Shokooh Saremi; Maryam Shahryari; Razieh Ghoorchian; Hamed Eshaghian; Seyed Amir Jalali; Amin Reza Nikpoor; Mahmoud Reza Jafari; Ali Badiee
Journal:  Iran J Basic Med Sci       Date:  2018-05       Impact factor: 2.699

8.  Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles.

Authors:  Wei Zhang; Yunmei Song; Preethi Eldi; Xiuli Guo; John D Hayball; Sanjay Garg; Hugo Albrecht
Journal:  Int J Nanomedicine       Date:  2018-01-09

9.  Resolution Agonist 15-epi-Lipoxin A4 Programs Early Activation of Resolving Phase in Post-Myocardial Infarction Healing.

Authors:  Vasundhara Kain; Fei Liu; Veronika Kozlovskaya; Kevin A Ingle; Subhashini Bolisetty; Anupam Agarwal; Santosh Khedkar; Sumanth D Prabhu; Eugenia Kharlampieva; Ganesh V Halade
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

10.  Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach.

Authors:  Lucia Ruxandra Tefas; Bianca Sylvester; Ioan Tomuta; Alina Sesarman; Emilia Licarete; Manuela Banciu; Alina Porfire
Journal:  Drug Des Devel Ther       Date:  2017-05-25       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.